The most commonly reported side-effects of recombinant interferon-β1a and 1b include local inflammatory injection site reactions, headache, fever, myalgia and a flu-like syndrome. In this case report, we describe the occurrence of cutaneous necrosis and dermal fibrosis following intramuscular interferon-β1a injections in a multiple sclerosis patient. © 2004 European Academy of Dermatology and Venereology
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
A 25-year-old male with relapsing-remitting multiple sclerosis (RRMS) presented with three transient...
Glatiramer acetate (GA) and interferon-beta (IFN-?) are disease-modifying therapies (DMTs) for multi...
Multiple sclerosis (MS) is a chronic and debilitating inflammatory autoimmune disorder of the centra...
Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Alth...
Interferons are widely used platform therapies as disease-modifying treatment of patients with multi...
Interferons are widely used platform therapies as disease-modifying treatment of patients with multi...
PubMed ID: 31046913Interferon beta (IFNß) is a drug used successfully in the treatment of multiple s...
Interferon alpha and gamma have been used to treat several hepatic, hematological and oncological di...
peer reviewedThe alpha, beta and gamma recombinant interferons are indicated in a growing spectrum o...
textabstractGlatiramer acetate and interferon-beta are approved first-line disease-modifying treatme...
A 54-year-old woman with hairy cell leukemia developed severe polymorphic erythema and blisters on t...
Recombinant interferon (IFN) β-1b was approved by the US Food and Drug Administration as the first d...
Abstract Cutaneous reactions associated with interferons (IFNs) treatment are either localized or ge...
Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscu...
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
A 25-year-old male with relapsing-remitting multiple sclerosis (RRMS) presented with three transient...
Glatiramer acetate (GA) and interferon-beta (IFN-?) are disease-modifying therapies (DMTs) for multi...
Multiple sclerosis (MS) is a chronic and debilitating inflammatory autoimmune disorder of the centra...
Interferon beta (IFNβ) is a drug used successfully in the treatment of multiple sclerosis (MS). Alth...
Interferons are widely used platform therapies as disease-modifying treatment of patients with multi...
Interferons are widely used platform therapies as disease-modifying treatment of patients with multi...
PubMed ID: 31046913Interferon beta (IFNß) is a drug used successfully in the treatment of multiple s...
Interferon alpha and gamma have been used to treat several hepatic, hematological and oncological di...
peer reviewedThe alpha, beta and gamma recombinant interferons are indicated in a growing spectrum o...
textabstractGlatiramer acetate and interferon-beta are approved first-line disease-modifying treatme...
A 54-year-old woman with hairy cell leukemia developed severe polymorphic erythema and blisters on t...
Recombinant interferon (IFN) β-1b was approved by the US Food and Drug Administration as the first d...
Abstract Cutaneous reactions associated with interferons (IFNs) treatment are either localized or ge...
Background: Secondary thrombotic thrombocytopenic purpura (TTP) due to interferon beta-1a intramuscu...
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
A 25-year-old male with relapsing-remitting multiple sclerosis (RRMS) presented with three transient...
Glatiramer acetate (GA) and interferon-beta (IFN-?) are disease-modifying therapies (DMTs) for multi...